Prolonged activation of glutamate receptors leads to excitotoxicity. Several processes such as reactive oxygen species (ROS) production and activation of the calcium-dependent protease, calpain, contribute to glutamate-induced damage. It has been suggested that the ROS-producing enzyme, NADPH oxidase (NOX), plays a role in excitotoxicity. Studies have reported NOX activation after NMDA receptor stimulation during excitotoxic damage, but the role of non-NMDA and metabotropic receptors is unknown. We evaluated the roles of different glutamate receptor subtypes on NOX activation and neuronal death induced by the intrastriatal administration of glutamate in mice. In wild-type mice, NOX2 immunoreactivity in neurons and microglia was stimulated by glutamate administration, and it progressively increased as microglia became activated; calpain activity was also induced. By contrast, mice lacking NOX2 were less vulnerable to excitotoxicity, and there was reduced ROS production and protein nitrosylation, microglial reactivity, and calpain activation. These results suggest that NOX2 is stimulated by glutamate in neurons and reactive microglia through the activation of ionotropic and metabotropic receptors. Neuronal damage involves ROS production by NOX2, which, in turn, contributes to calpain activation.
INTRODUCTION
Glutamate neurotoxicity is triggered by a calciumdependent mechanism known as excitotoxicity (1, 2) . Excitotoxicity has been associated with cerebral ischemia, hypoglycemia, and some neurodegenerative disorders. It mainly involves the activation of the N-methyl-D-aspartate (NMDA) receptor subtype (3) , but kainate and >-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor agonists are also potent excitotoxins (4, 5) . The stimulation of ionotropic receptors leads to calcium influx, production of reactive oxygen species (ROS), and activation of calpain; the stimulation of group 1 metabotropic receptors mGluR1 and mGluR5 induces the release of calcium through IP 3 receptors. Several studies show that exposure to glutamate or its analogs results in the production of superoxide anion, nitric oxide, and hydroxyl radicals (6Y10) and that antioxidants prevent excitotoxic damage in in vitro and in vivo models (11, 12) . Several sources contribute to ROS production during excitotoxicity, including mitochondria and Ca
2+
-dependent enzymatic pathways, such as nitric oxide synthase, xanthine oxidase, and phospholipase A 2 (13Y17). More recently, NADPH oxidase has also been implicated (18, 19) .
NADPH oxidase is a multimeric enzyme that reduces oxygen to form superoxide anion; it was originally described in phagocytic cells, where it is composed of 2 membrane (gp91 phox and p22 phox ) and 3 cytosolic (p47 phox , p67 phox , and p40 phox ) subunits (20, 21) . Recent studies have demonstrated that NADPH oxidase has several homologs, termed NOX1 to NOX5 (for NADPH oxidase). NOX2 corresponds to gp91 phox described in phagocytic cells (22, 23) . NOX family members are expressed in a wide variety of nonphagocytic cells, including neurons, astrocytes, and microglia (24Y26), and it has been suggested that they play a role in apoptotic death in cultured neurons (25Y29).
Inhibition of NOX activity attenuates ROS production induced by NMDA in cortical neurons (19, 30) and prevents oxidative damage and neuronal death induced by cerebral ischemia in vivo (31, 32) . Furthermore, mice lacking a functional NOX enzyme show reduced superoxide anion production and are more resistant to ischemia and NMDA-induced damage (18, 32Y34) . The role of NOX in excitotoxic neuronal death is not completely understood. Recently, an effect of NOX on the activation of calpain has been reported (32, 35) , suggesting a link between ROS produced by NOX and the activation of this calcium-dependent protease, an important mediator of excitotoxic neuronal death (36Y38). Most studies investigating the role of NOX in excitotoxic damage have focused on NMDA receptors, whereas the contribution of non-NMDA and metabotropic receptors has not been elucidated.
Glutamate, as the endogenous neurotransmitter, activates all glutamate receptors subtypes. Ionotropic glutamate receptors are located in the striatum and are present in GABAergic medium spiny projection neurons, the most abundant neuronal subtype in this brain region (39Y41). These neurons are preferentially lost after the administration of excitotoxins (42) and are sensitive to NMDA, kainate, and >-amino-3-hydroxy-5-methyl-4-isoxazole propionate neurotoxicity (39, 43, 44) . On the other hand, group 1 metabotropic receptors, mGluR1 and mGluR5 are also present in medium spiny neurons (45, 46) . On the basis of these observations, it is expected that the different glutamate receptor subtypes would contribute to neuronal death and NOX activity. Here, we aimed to evaluate the role of ionotropic and metabotropic glutamate receptors on NOX2 activation and neuronal death induced by glutamate intrastriatal administration in wild-type and NOX2 knockout (NOX2 KO) mice. We also investigated whether glutamateinduced calpain activation in vivo is related to NOX2 activity.
MATERIALS AND METHODS
All animals were handled according to the National Institutes of Health Guide for the Care and Use of laboratory animals (NIH Publication No. , and the local animal care committee approved all animal treatments. All efforts were made to minimize the number of animals used and their suffering. The NOX2 KO (gp91 phoxj/j ) mice generated on a C57BL/6 background were purchased from The Jackson Laboratory (Bar Harbor, ME), and the colony was established at the vivarium of the Instituto de Fisiología Celular at the Universidad Nacional Autónoma de Mexico. Mice were housed and kept under controlled temperature (20-CY22-C) with a regulated 12-hour light-dark cycle.
Intrastriatal Glutamate Injection
Glutamate-induced neurotoxicity in the striatum was evaluated in NOX2 KO and wild-type mice. The effect of glutamate receptor antagonists, the NOX inhibitor apocynin, the spin trapper >-phenyl-N-tert-butyl nitrone PBN, and the calpain inhibitor MDL-28170 on glutamate-induced damage was evaluated in wild-type animals. These compounds were injected intraperitoneally (i.p.). Apocynin solution (15 mg/kg in 10% dimethyl sulfoxide [DMSO]) was administered 4 hours before glutamate injection; the NMDA receptor blocker, memantine (30 mg/kg in 0.9% saline solution) was injected 1 hour before glutamate injection; the nonYNMDA receptor antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[ f ]quinoxaline-2,3-dione (NBQX, 20 mg/kg) was administered 15 minutes before, immediately after, and 15 minutes after glutamate injection, with a total dose of 60 mg/kg; the mGluR1 receptor antagonist, (S)-(+)-A-amino-4-carboxy-2-methyl benzeneacetic acid (LY367385, 5 mg/kg) was administered 30 minutes before and 30 minutes after glutamate injection (total dose, 10 mg/kg); 3 doses of the mGluR5 antagonist (RS)->-methyl-4-phosphonophenylglycine (MPEP, 3.3 mg/kg) were injected 30 minutes before, immediately after, and 1 hour after glutamate injection (total dose, 10 mg/kg). >-Phenyl-N-tert-butyl nitrone (50 mg/kg) was dissolved in 50% DMSO/10 mmol/L phosphate buffer, and 2 doses were administered 1 hour before and 2 hours after glutamate. The calpain inhibitor MDL-28170 (Biomol, Plymouth Meeting, PA) was dissolved in DMSO, and 3 doses were given i.p. to the animals (1 dose of 20 mg/kg was injected 30 minutes before glutamate administration and 2 doses of 15 mg/kg were injected immediately and 1 hour after glutamate). All glutamate receptor antagonists were purchased from Tocris (Ellisville, MO); PBN and apocynin were from Sigma (St Louis, MO). Doses of the different inhibitors were chosen according to studies showing their effectiveness in preventing excitotoxic damage (34, 47Y52) . For glutamate receptor antagonists, the effectiveness of the different treatments to prevent glutamate toxicity was previously tested in a group of CD1 strain mice. All antagonists significantly reduced the lesion volume in these animals at the concentrations used (data not shown).
Animals were anesthetized with 2% to 3% halothane in 95% O 2 /5% CO 2 mixture and placed on a stereotaxic frame (David Kopf Instruments, Tujunga, CA). A stainless needle was positioned in the right striatum according to the coordinates: anterior-posterior +0.8 mm from bregma, lateral +2.2 mm from midline, and vertical j3.2 mm from dura (53) . We have previously shown that 500 nmol of glutamate induces a significant lesion in the mice striatum compared with saline injections (54) . A fresh solution of monosodium glutamate (500 nmol/0.5 Kl, pH 7.0) was injected at a rate of 0.175 Kl/min with the aid of an injection pump (apparatus pump model 55; Harvard, South Natick, MA). Five minutes after the injection, the needle was gently withdrawn, and the skin was sutured. Mice were allowed to recover from anesthesia and placed in individual cages with water and food ad libitum.
Histology
Glutamate-induced lesions were evaluated 24 hours after the surgery. Mice were deeply anesthetized with sodium pentobarbital and transcardially perfused with 25 ml of 0.9% saline solution followed by 35 ml of 3.7% formaldehyde solution (in 0.1 mmol/L phosphate buffer, pH 7.3). Brains were removed and placed in the same fixative solution at 4-C. Consecutive series of striatal coronal sections (40 Km thick) for cresyl violet staining and Fluoro Jade B (FJB; Chemicon, Temecula, CA) staining were obtained in a vibratome (VT 1000s; Leica, Microsystems Nussloch GmbH, Heidelberger Nussloch, Germany). After staining with cresyl violet, sections containing a lesion in the striatum were selected for quantification of lesion volumes. The damaged areas (observed as a pale region with pyknotic nuclei and a reduced number of cell somata) were delineated manually and measured using an image analyzer (NIH Macintosh Image 1.6) by an experimenter blinded to the treatments. Total lesion volume was obtained from the sum of all damaged areas multiplied by the width of the sections (40 Km).
FJB Staining
Fluoro Jade B staining was performed as previously described (54) . One drop of 1% NaOH solution diluted in 80% ethanol was added to the coronal sections mounted on slides, and after 2 minutes, it was replaced by a 70% ethanol solution. Slides were covered with 0.06% potassium permanganate for 10 minutes, and then brain sections were washed and incubated for 10 minutes with a 0.0004% FJB solution prepared in 0.1% acetic acid. Finally, the sections were washed, dried at 50-C, dehydrated with xylol, and covered with Permount (Fisher Scientific, Fair Lawn, NJ). Slices were observed under an epi-fluorescence microscope (Olympus Corporation, Tokyo, Japan) using a U-MNB2 filter (395Y590 nm) and total FJB-positive cells were counted (Image-Pro Plus 6.0 analyzer program; Media Cybernetics Inc, Bethesda, MD) in the entire striatum in 3 sections per mouse, namely, the section containing the needle tract (middle section) and the adjacent anterior and posterior sections located 160 Km away from the middle section.
ROS Determination in the Striatum
Mice were given dihydroethidium solution (DHE, 25 mg/kg; Invitrogen, Molecular Probes, Eugene, OR) solubilized in 100% DMSO i.p. 30 minutes before glutamate intrastriatal injection. Dihydroethidium is a cell-permeable dye that is converted to ethidium (Et) that, when oxidized, binds to DNA, emitting red fluorescence in the nuclei (55) . Dihydroethidium has been used as a marker for superoxide anion because of its relative specificity for this ROS (56, 57) . However, it can also be oxidized by other reactive species, such as H 2 O 2 , ONOO j , and hydroxyl radical, thereby providing an index of the production of reactive nitrogen species and ROS (55, 57, 58) . Glutamate-induced ROS formation was evaluated 12 hours after the surgery; animals were deeply anesthetized and transcardially perfused with 0.9% saline solution followed by 35 ml of 4% paraformaldehyde (in 0.1 mmol/L phosphate buffer, pH 7.3). Brains were stored at 4-C and transferred successively to 20% and 30% sucrose solutions (24 hours each) for cryoprotection. Coronal 25-Km sections were obtained in a cryostat, mounted, and stained with the nuclear dye Hoechst 33258 (0.001% in phosphate-buffered saline [PBS]; Sigma) for 15 minutes. Slides were washed and covered with Fluoromount-G (EMS, Hatfield, PA) and maintained at 4-C until examination. Preparations were observed under an epifluorescence Olympus microscope using a U-MNG2 filter (universal narrow green, 528Y605) and a U-MNU filter (universal mirror narrow ultraviolet, 355Y465) for Et and Hoechst, respectively. Ethidium fluorescence was quantified (Image-Pro Plus 6.0 analyzer program) in the entire striatum in 3 sections per mouse (the middle section containing the needle tract and the adjacent anterior and posterior sections). Data are expressed as arbitrary fluorescence units.
Immunohistochemistry
After animals were perfused, the brains were extracted and 25-Km-thick coronal sections obtained in a cryostat. They were blocked for 1 hour in PBSYALB-T (0.1 mol/L PBS/5% albumin/0.3% Triton X-100) and incubated for 72 hours at 4-C with a primary antibody. The sections were washed and incubated for 2 hours at room temperature with the corresponding secondary antibody in PBSYALB-T, washed and covered with Fluoromount-G (EMS), and maintained at 4-C until examination. The following antibodies were used: mono- For double immunohistochemistry, in all cases, primary antibodies were coincubated simultaneously except for NOX2/NeuN. In that case, anti-NOX2 was incubated and developed with the secondary antibody DyLight 514, and sections were washed and incubated with anti-NeuN for 24 hours at 4-C and developed with DyLight 488 antibody. Quantification of cells colabeled for NeuN and NOX2 or Iba1 and NOX2 was performed manually from images taken by confocal microscopy. Three fields from the dorsal striatum per section per animal were analyzed (wild-type animals killed 6 and 24 hours after glutamate administration; 3 animals per group). Data are expressed as the percentage of cells colabeled with Neu-N/NOX2 or Iba1/NOX2 from the total NeuN-positive or Iba1-positive cells present in the 3 fields.
The analysis and quantification of 3-nitrotyrosineY positive cells was made by epifluorescence using an Olympus microscope U-MNB2 filter (395Y590 nm). NT-positive cells were counted (Image-Pro Plus 6.0 analyzer program) in the entire striatum in 3 sections per mouse. Some sections were incubated with NT antibody and polyclonal antibody against GFAP (1:1000 dilution), as previously described (59) (not shown). Samples were analyzed by confocal laser scanning microscopy (FV 1000; Olympus) using a 40Â plan FLN-NA 1.3 objective, motorized FV10ASW 2.1, with Ar 488 laser (for FITC and DyLight 488) and HeNe 543 laser (for DyLight 594 and Texas Red).
NADPH Oxidase Activity
NADPH oxidase activity was determined in striatal homogenates at different times (0.5, 3, 6, and 12 hours) after glutamate administration in wild-type mice. Maximal NADPH oxidase activity was observed 3 hours after glutamate administration and remained elevated 6 and 12 hours after the injection. Therefore, the effect of apocynin on enzyme activity was assessed 3 hours after glutamate injection, whereas that of glutamate receptor antagonists was evaluated 3 and 6 hours after the surgery in both NOX2 KO and wild-type animals. After treatment with glutamate receptor antagonists, animals were killed and tissues were dissected. The injected striata were homogenized in a buffer containing (in mmol/L): 25 HEPES, 1 EDTA, and 0.1 phenylmethylsulfonyl fluoride. After centrifugation of the homogenates at 15,000 rpm for 6 minutes at 4-C, the supernatants containing the membrane and cytosolic components were separated and used for the NADPH oxidase activity determination. NADPH oxidase activity was estimated as the oxidation of DHE to Et by the superoxide anion formed using the method described by Satoh et al (60) . Briefly, tissue homogenates were incubated with 0.02 mmol/L DHE, 0.5 mg/ml salmon testes DNA, and 0.2 mmol/L NADPH as substrate. Et-DNA fluorescence was measured during 30 minutes at an excitation wavelength of 480 nm and an emission of 610 nm using a Synergy HT multidetection fluorescence microplate reader (Biotek Instruments, Colchester, VT). Samples were measured in duplicate, and NADPH oxidase was expressed as the change in Et fluorescence per milligram per hour. Some samples were incubated in the presence of 1 Kmol/L of the NOX inhibitor diphenyleneiodonium (DPI; Sigma) to corroborate the specificity of the assay.
Western Blotting
Calpain activation was assessed by Western blotting using an antibody that recognizes the complete >-spectrin and the fragments generated by calpain activation (145/150 kDa), as previously described (52) . Briefly, mice were killed 6 hours after glutamate injection, and the striatum was dissected and homogenized in ice-cold buffer containing: 20 mmol/L HEPES-KOH (pH 7.4), 0.1% Triton X-100, 5 mmol/L MgCl 2 , 1.3 mmol/L EDTA, 1 mmol/L EGTA, and a cocktail of protease inhibitors (Roche, Mannheim, Germany). Homogenates were centrifuged at 15,000 Â g, and the supernatant was stored at j80-C until analysis. Protein content was quantified by the Lowry method, and 25 Kg was electrophoresed in sodium dodecyl sulfateYpolyacrylamide gel electrophoresis (7%) and then transferred to nitrocellulose membranes. Monoclonal antibodies against >-spectrin (1:2500; Chemicon) and actin (1:7500; Chemicon) were incubated overnight at 4-C. Antimouse horseradish peroxidaseYconjugated antibody (1:3000 for >-spectrin and 1:5000 for A-actin) was incubated for 2 hours, and peroxidase activity was detected using ECL reagent (ECL; Millipore). The blots were exposed to x-ray films, and the autoradiographs were scanned. Densitometric analysis was performed using the NIH Image/ImageJ program. The optical density values of the 145-and 150-kDa bands were considered as single data because the 2 bands were observed as a single one. Data are expressed as the ratio of the 145-to 150-kDa band/actin. The effect of apocynin and MDL-28170 on calpain activity was tested in animals treated as described previously at 12 or 24 hours after glutamate administration.
Calpain Activity Assay
Calpain activity was monitored in striatal homogenates of wild-type animals and NOX2 KO. A group of wild-type animals was treated with apocynin 4 hours before glutamate intrastriatal injection. In all cases, animals were killed 12 hours after the administration of glutamate. Calpain activity was determined using the fluorogenic substrate N-succinyl-Leu-Tyr-7-amido-4-methylcoumarin (N-succinyl-Leu-Tyr-AMC; Sigma S1153), as previously described with some modifications (61). Brain homogenates (50 mg of protein) were preincubated at 37-C in a buffer containing 63 mmol/L imidazole-HCl, pH 7.3, 10 mmol/L A-mercaptoethanol and 5 mmol/L CaCl 2 , for 10 minutes. The fluorogenic substrate (200 mmol/L) was added, and fluorescence emission (360-nm excitation/460-nm emission) was monitored for 40 minutes using a Synergy HT multidetection microplate reader (Biotek). The nonYcalciumdependent fluorescence was measured under the same conditions using a buffer not containing calcium but containing 1 mmol/L EDTA and 10 mmol/L EGTA. Calcium-dependent cleavage activity toward N-succinyl-Leu-Tyr-AMC is reported as the change in fluorescence per minute per milligram of protein. To corroborate that the measured fluorescence corresponds to substrate cleavage by calpain, control experiments were performed using the specific calpain inhibitor MDL-28170, which was added to the incubation buffer at a 10 Kmol/L concentration.
Statistical Analysis
Data were analyzed by one-way analysis of variance followed by a Fisher multiple comparison post hoc test. Significant differences were considered when p e 0.05. Data are expressed as mean T SEM.
RESULTS

NOX2-Deficient Animals Are Less Vulnerable to Glutamate-Induced Damage
NOX2 KO and wild-type animals were intrastriatally injected with glutamate or saline solution, and 24 hours, later tissue injury was evaluated by cresyl violet and FJB staining. Lesions induced by glutamate in the wild-type and NOX2 KO mice were significantly larger than those in saline-injected mice (Fig. 1A) . The lesion volume as evaluated in cresyl violetYstained sections was 3.7-fold larger in wild-type mice than in NOX2 KO animals (0.966 T 0.126 and 0.301 T 0.036 mm 3 , respectively; Fig. 1B) . Accordingly, wild-type animals treated with the NADPH oxidase inhibitor, apocynin, showed a significant reduction (60%) of the lesion volume (0.454 T 0.101 mm 3 ; Fig. 1B ). Because NADPH oxidase activity is related to superoxide anion production and oxidative stress is involved in excitotoxic neuronal damage, we tested whether the spin trapper PBN was able to reduce glutamate-mediated injury. As shown Figure 1B , PBN was as effective as apocynin in reducing the lesion volume to 0.386 T 0.058 mm 3 . Representative images of brain sections from animals receiving apocynin and PBN treatments are shown in Figure 1A .
Numbers of degenerating FJB-positive cells were counted in tissue sections from animals killed 24 hours after glutamate injection (Fig. 1D) . Larger numbers of damaged cells were found in NOX2 KO and wild-type animals injected with glutamate versus saline-injected animals. In agreement with the lesion volume measurements, the number of FJB-positive cells in wild-type animals almost doubled that observed in NOX2 KO mice. Again, apocynin and PBN significantly reduced the number of damaged cells in wild-type animals reaching the levels found in NOX2 KO mice (Fig. 1D) . Representative tissue sections from wild-type and NOX2 KO animals showing FJB-labeled cells are shown in Figure 1C .
Together, these results suggest that NOX2 is involved in cell death induced by glutamate, possibly through the generation of ROS and oxidative damage.
Glutamate Stimulates ROS Production and NADPH Oxidase Activity
Levels of ROS in the striatum of injected animals were evaluated 12 hours after glutamate or saline administration. Formation of ROS was quantified through the oxidation of DHE to Et. Significantly increased ROS levels were detected in glutamate-injected versus saline-treated animals ( Fig. 2A) . As expected, DHE oxidation was lower in NOX2 KO animals compared with wild-type mice. Moreover, in wild-type animals treated with apocynin, the levels of Et-fluorescence decreased to those observed in NOX2 KO mice ( Fig. 2A) .
During the excitotoxic cascade, superoxide anion reacts with nitric oxide producing peroxynitrite; it then reacts with tyrosine residues of proteins. Thus, the presence of nitrosylated proteins can be used as an index of oxidative damage. We investigated whether NT-positive cells were present in the striatum of wild-type and NOX2 KO animals 12 hours after glutamate injection. As shown in Figure 2B , wild-type mice injected with glutamate showed a significantly higher number of NT-positive cells in the striatum compared with NOX2 KO mice, which is in agreement with the observed ROS levels. Furthermore, inhibition of NOX by apocynin significantly reduced the number of NT-positive cells to the levels present in NOX2 KO. Representative images of brain sections showing NT-positive cells are shown in Figure 2C . Immunohistochemical analysis indicates that NT-positive cells do not correspond to astrocytes because no coimmunolocalization with astrocyte markers was observed (data not shown).
NADPH oxidase activity was measured in the striatum of wild-type mice at different times after glutamate injection (0.5, 3, 6, and 12 hours). No increase in enzyme activity over basal levels was detected after 30 minutes of glutamate injection; however, a significant increase was observed after 3 hours, which remained high at 6 (Fig. 3A) and 12 hours (data not shown). The NOX inhibitor DPI was used to corroborate the specificity of the assay. The increase in the enzyme activity observed at 6 hours after glutamate injection was completely abated by DPI (saline, 118.3 T 5.6; glutamate, 218.4 T 13.5; glutamate + DPI, 134.3 T 14.3; n = 3). These results correlate with the Et fluorescence observed 12 hours after the injection of glutamate (Fig. 2A) . We next measured NOX activity 3 hours after glutamate injection in NOX2 KO mice and wild-type animals treated with apocynin. As expected, no significant NADPH oxidase activity was induced by glutamate in NOX2 KO mice, and apocynin completely abated glutamate-induced NADPH oxidase activity in wildtype mice, reaching levels close to those in NOX2 KO and saline-injected animals (Fig. 3B) . These results indicate that activation of glutamate receptors leads to NOX2 activation and ROS production.
Next, we aimed to evaluate whether the stimulation of NADPH activity induced by glutamate could be attributed to NOX2 present in neurons or microglial cells because the enzyme is present in both cell types. The progress of microglial reactivity after glutamate administration was followed by immunohistochemistry using the microglial marker Iba1 (Fig. 4) . In saline-injected mice, Iba1-positive cells are present, but they show a normal morphology (Fig. 4A) . After 3 hours of glutamate injection, the tissue looked similar to the tissue of control animals except that a few cells show features of reactive microglia (arrow, Fig. 4B ), whereas at 6 hours and particularly at 24 hours, numerous Iba1-positive cells showing morphologic features of reactive microglia, such as enlarged cell bodies and retracted processes are present (arrows in Figs. 4C, D) . The presence of reactive microglia correlates with the loss of NeuN-positive cells at 24 hours, suggesting the presence of an inflammatory reaction (Fig. 4D) . In NOX2 KO mice, only a few reactive microglial cells were observed, and many NeuN-positive cells are visible, as in saline-treated wildtype mice (Fig. 4F) . No reactive microglia were observed in NOX2 KO animals injected with saline (Fig. 4E) .
We next investigated whether NOX2 enzyme is present in neurons or activated microglia. Double immunolabeling using an antibody against the gp91 phox subunit of NOX2 (anti-gp91 phox ) and either NeuN or Iba1 antibodies was performed at different times after glutamate intrastriatal administration. In wild-type mice, 3 (not shown) and 6 hours (Fig. 5A , top panels) after glutamate administration, gp91 phoxpositive, NeuN-positive cells were observed in tissue sections close to the injection site. From the total NeuN-positive cells, 86.4% T 5.88% were immunopositive for gp91 phox (n = 3). On the other hand, whereas no cells immunoreactive to Iba1 and gp91 phox were observed at 3 hours (data not shown), some of the Iba1-positive cells were also immunoreactive for gp91 phox at 6 hours near the lesion site (arrows in Fig. 5A, bottom   FIGURE 3 . Glutamate (Glu)Yinduced activation of NADPH oxidase in the striatum of NADPH oxidase knockout (NOX2 KO) and wild-type mice. (A) NADPH oxidase activity in homogenates of the striatum of wild-type mice at different times after Glu (500 nmol) injection. (B) NADPH oxidase activity in homogenates of the striatum of NOX2 KO and wild-type mice 3 hours after the injection of saline or Glu. Wild-type mice were also treated with apocynin (Apo). Data are mean T SEM of 3 to 7 independent experiments. *, p G 0.05 relative to the saline group; &, p G 0.01 relative to Glu-injected wild-type mice. panels). Of the total of Iba1-positive cells, 17.3% T 6.6% were also immunoreactive for gp91 phox at this time (n = 3). At 24 hours, only a few NeuN-positive cells immunoreactive for gp91 phox were observed near the injection site, 11.2% T 1.8% (n = 3; Fig. 5B, top panels) . The extent of gp91 phox / NeuN coimmunolabeling observed at 24 hours was significantly less than that observed at 6 hours (p G 0.001). In contrast, many neurons positive for gp91 phox were present in sections farther away from the site of the lesion (insets in Fig. 5B, top panels) . This can be explained by the loss of neurons near the injection site, in contrast to the preservation of the tissue beyond the lesion. At 24 hours, there was a notable increase in gp91 phox /Iba1 immunoreactivity in cells showing the morphology of activated microglia. From the total of Iba1-positive cells, 52.1 T 6.5 (n = 3) were also immunoreactive for gp91 phox (arrows in Fig. 5B, bottom panels) . The percentage of gp91 phox /Iba1-immunoreactive cells at 24 hours was statistically greater than that observed at 6 hours (p G 0.05). In contrast, NOX2 KO mice showed a reduced number of reactive microglial cells, which correlates with scarce immunoreactivity to gp91 phox (Fig. 5C) . Similarly, very few gp91 phox -positive neurons were observed in NOX2 KO mice 24 hours after glutamate administration (not shown). No gp91 phox immunoreactivity was observed in saline-injected wild-type or NOX2 KO mice (not shown).
Ionotropic and Metabotropic Glutamate Receptors Contribute to NADPH Oxidase Activity and Glutamate-Induced Damage
The effect of glutamate receptor antagonists on neuronal damage was studied through the evaluation of the lesion volume and the number of degenerating neurons positive to FJB 24 hours after the surgery. As expected, the NMDA receptor blocker memantine effectively reduced both the lesion volume and the number of FJB-positive cells by È70% to 90% (Figs. 6A, B) . The non-NMDA receptor antagonist NBQX and the metabotropic glutamate receptor antagonists, LY367385 and MPEP (for mGluR1 and mGluR5, respectively), also significantly reduced the number of degenerating cells (by 40%Y60%), although MPEP did not significantly reduce the lesion volume (Fig. 6A) .
On the basis of these findings, we aimed to test whether the different glutamate receptors subtypes contribute to NADPH oxidase activation. Three hours after glutamate injection, NADPH oxidase activity was completely blocked by all glutamate receptor antagonists (Fig. 7A) . At 6 hours, the enzyme activity remained low in animals treated with memantine and MPEP, whereas NBQX and LY367385 were unable to sustain enzyme inhibition at this time at the concentrations tested (Fig. 7B) .
Glutamate-Induced Calpain Activation in Wild-Type and NOX2 KO Animals and Its Role in Cell Damage
We previously reported that the calcium-dependent protease, calpain, is promptly activated after glutamate administration in the rat striatum and that its inhibition prevents glutamate toxicity induced in vivo (52) . Thus, we decided to evaluate whether this component of the excitotoxic cascade is also attenuated in NOX2 KO mice.
Calpain activity was monitored by the immunodetection of the calpain-induced breakdown products of >-spectrin. No processing of >-spectrin was observed after 6 hours of treatment with saline in both NOX2 KO and wild-type animals (Figs. 8A, B) . In contrast, treatment of wild-type animals with glutamate induced the generation of the 145/150-kDa bands, corresponding to >-spectrin cleavage by the action of calpains (Figs. 8A, B) . In NOX2 KO mice treated with glutamate, the 145/150-kDa bands were less evident than in wild-type mice, and in some animals, they were completely absent (Fig. 8A) . Thus, the density of these bands was significantly reduced in NOX2 KO mice (Fig. 8B) . Treatment with apocynin in wildtype mice reduced the density of the 150/145-kDa spectrin bands, suggesting that NOX activity is involved in protease activation (Fig. 8C) . To corroborate this result, calpain activity was monitored using a fluorometric substrate 12 hours after glutamate administration in animals previously treated with apocynin. As shown in Figure 8D , calpain activity was stimulated in animals injected with glutamate and apocynin completely abated this effect. In contrast, in NOX2 KO mice, glutamate did not stimulate calpain activity. As expected, no enzyme activity was detected when the calpain inhibitor, MDL-28170, was added to the samples (data not shown).
The effect of MDL-28170 on the cleavage of >-spectrin and the lesion volume was tested in wild-type animals. The 145/150-kDa spectrin fragments were markedly reduced in animals treated with the inhibitor, as monitored 12 hours after glutamate injection (Fig. 9A) . Furthermore, treatment with MDL-28170 reduced the lesion volume induced by glutamate to a similar extent as apocynin in wild-type animals, and cotreatment with both inhibitors did not exert further significant protection (Fig. 9B) . In NOX2 KO mice, MDL-28170 showed no effect on the size of the lesion (Fig. 9B) .
DISCUSSION
Excitotoxicity is involved in neuronal damage associated with a number of pathologic conditions, including acute neurologic disorders such as ischemia, trauma, and hypoglycemia and some neurodegenerative diseases such as Huntington disease (62Y65). It has been suggested that oxidative damage plays a role in excitotoxic death; however, the sources of ROS generation and its relative contribution to cell damage have not been completely elucidated. Recently, superoxide production resulting from NOX activity has been observed in experimental conditions associated with excitotoxic insults, and its role in neuronal death has been suggested (18, 31, 32, 34, 66) . The role of superoxide on excitotoxicity is further supported by previous experiments showing that overexpression of superoxide dismutase, an enzyme that dismutates superoxide anion to H 2 O 2 , renders animals less vulnerable to kainic acid and NMDA neurotoxicity in the striatum; knockout animals for this enzyme show exacerbated toxicity (67) .
Previous studies have shown that mice lacking the NADPH-oxidase cytosolic subunit p47 phox are less vulnerable to ischemic, hypoglycemic, and NMDA-induced neuronal damages (18, 34, 66) . On the other hand, the mechanisms involving the different NOX homologues (particularly NOX2, one of the most studied catalytic subunits of NADPH-oxidase) in the excitotoxic cascade are not completely understood. We explored this issue using NOX2 KO mice lacking the membrane-bound catalytic gp91 phox (NOX2) subunit (68) , which is present in neurons in various CNS regions, including the striatum (26, 69, 70 ). The contribution of the different glutamate receptor subtypes to NOX activity is still unknown.
Using an in vivo model of neuronal damage triggered by the administration of glutamate into the striatum, we show that NOX2-deficient mice are considerably less vulnerable than wild-type mice to glutamate-mediated excitotoxicity.
Neuronal damage observed in NOX2 KO mice was very similar to that observed in wild-type animals treated with the spin trapper PBN and the general inhibitor of NOX, apocynin, supporting the role of oxidative stress generated by NOX2 in glutamate-induced damage. However, because glutamate neurotoxicity is not completely attenuated in NOX2 KO mice, other toxic cascades, such as the activation of nitric oxide synthase, xanthine oxidase, and phospholipase A 2 (7, 9, 15Y17), must be considered. In addition, mitochondrial dysfunction and ROS production resulting from mitochondrial calcium overload might also be involved because these have been shown to be directly involved in glutamate neurotoxicity (71) .
Neuronal damage correlated well with the DHE data showing that glutamate-induced ROS production is considerably reduced in NOX2 KO mice as well as in wild-type mice treated with apocynin. In addition, ROS production results in protein-oxidative modification as a higher number of NTpositive cells observed in wild-type than in NOX2 KO mice. Together, the results indicate that oxidative damage triggered by NOX2 is involved in excitotoxic neuronal death. This hypothesis is supported by data on NOX activity, because the enzyme is activated from 3 hours after glutamate administration in wild-type, but not in NOX2 KO mice.
NOX2 can be detected by immunohistochemistry in neurons and reactive microglia as soon as 3 hours after glutamate injection in the tissue near the site of injection. At 24 hours, when there is an evident loss of neurons and microglial reactivity, NOX2 immunolabeling is markedly reduced in neurons near the injection site, whereas NOX2 expression increases in reactive microglia surrounding the lesion. In the tissue beyond the lesion site, where neurons are still preserved, NOX2 immunoreactivity is clearly enhanced in neurons at 24 hours. These data lead us to conclude that the sustained increase in NOX activity observed after glutamate injection can be attributed to NOX2 present both in neurons and in reactive microglia. Early after glutamate injection, the predominant NOX2-immunoreactive cells are neurons, but as a progressive inflammatory reaction takes place, NOX2 becomes predominant in reactive microglia. NOX2 KO mice showed a more moderate microglial reactivity and only scarce immunolabeling for NOX2 in reactive microglia.
As expected, the results suggest that NMDA receptors are mostly involved in glutamate toxicity because only a few degenerating cells were observed in memantine-treated animals. However, non-NMDA and metabotropic glutamate receptors also contribute. We observed that all receptor antagonists (at the concentrations tested) similarly prevented enzyme activation at 3 hours after glutamate injection, whereas only the animals treated with memantine and the mGluR5 antagonist, MPEP, showed a significant reduction in NOX activity at 6 hours. These results correlate with the notable protective effect of memantine and with the partial protective effect elicited by NBQX and LY367385. The effect of LY367385 is in accordance with a recent study by Muritomi et al (72) showing that this compound reduces NOX activity and superoxide production induced after focal ischemia.
Long-term inhibition of NOX activity by glutamate receptor antagonists might be explained by a delayed release of glutamate from damaged neurons or from other cell types after injected glutamate has been cleared. Glutamate release from microglia has been suggested to mediate excitotoxicity during neuroinflammation (73) . Our observations suggest that glutamate antagonists might inhibit neuronal NOX activation induced by glutamate released from microglia long after the injected glutamate has been cleared, that is, when there is an inflammatory response present.
The contribution of glutamate receptors to enzyme activation and cell damage might be related to their permeability to calcium or their capacity to induce the release of calcium from IP 3 receptors. Previous reports suggest that protein kinase C activity is necessary for p47 phox membrane translocation and NOX activity (74, 75) . Because calcium activates protein kinase C, which phosphorylates the p47 phox subunit (74), NOX activation might result from calcium influx through glutamate ionotropic receptors. In this regard, it is known that both ionotropic and metabotropic glutamate receptors are located in medium spiny neurons in the striatum (39Y41), which are mostly damaged by NMDA, kainate and >-amino-3-hydroxy-5-methyl-4-isoxazole propionate (39, 43, 44) . The major protective effect of the NMDA receptor blocker might rather be attributable to the larger permeability of this receptor to calcium ions (76, 77) .
Group 1 mGluR, mGluR1 and mGluR5, are coupled to phospholipase C activation, IP 3 production and calcium release from the endoplasmic reticulum. Both subtypes are present in medium spiny neurons (45, 46) , but their role in striatal function has been controversial (78, 79) . LY367385 is a competitive inhibitor with selectivity for mGluR1 and has been shown to prevent neuronal damage induced by oxygen/ glucose deprivation and ischemia (50, 72, 80, 81) . Data on mGluR5 antagonists are more conflicting. (RS)->-methyl-4-phosphonophenylglycine, a noncompetitive mGluR5 receptor antagonist, has shown protection against global and focal ischemic damage in some studies (82Y84) but not in others (81) . In addition, activation of mGluR5 also reduces focal ischemic damage (84) , and this effect is possibly related to recent evidence suggesting that mGluR5 activation in microglia inhibits the release of proinflammatory factors, ROS production, and NOX activity on lipopolysaccharide stimulation (85Y87). Thus, activation of mGluR5 can exert either neuroprotective or neurotoxic actions. In the present study, we observed that MPEP (despite eliciting long-term inhibition of NOX activity) only partially reduced the number of damaged cells and induced no significant reduction of the lesion volume at the concentration tested. This apparent discrepancy might result from a combination of the effects of this antagonist on mGluR5 located on microglia and neurons. The low protective effect of MPEP could result from its antagonistic action on mGluR5 in reactive microglia, preventing the inhibitory effect of glutamate on the release of proinflammatory factors and ROS production (85Y87). In contrast, MPEP's inhibitory effect on NOX activity might result from its action on mGluR5 present in neurons.
The role of other components of the excitotoxic cell death cascade was also investigated. Calpains are calcium-dependent proteases activated by the stimulation of both non-NMDA and NMDA glutamate receptors (36Y38) and are well-known mediators of excitotoxic neuronal death (38, 52, 88Y90) . Also, there is evidence showing a relationship between calpain activation and oxidative stress during cell death. In vitro studies have shown that exposure to H 2 O 2 leads to intracellular calcium increase, calpain activation, and cell death (91Y93). Moreover, in vivo posttraumatic calpain activation is preceded by oxidative damage and the disruption of calcium homeostasis; these effects are prevented by an antioxidant (94) . In line with these observations, it was demonstrated that the superoxide dismutase/catalase mimetic EUK-134 reduces oxidative damage, calpain-mediated spectrin cleavage, and neuronal death induced by kainate, suggesting a role of superoxide in calpain activation (95) . These observations suggest a close relationship between the production of reactive species, oxidative damage, calpain-mediated proteolysis, and cell death. Furthermore, a role of NOX2 activity in calpain activation has recently been suggested because mice deficient in NOX2 are less vulnerable to ischemic injury and show reduced calpain-dependent spectrin cleavage (32) . In agreement with these observations, we observed that glutamate-induced calpain activity is significantly reduced in NOX2-deficient mice, as monitored by spectrin cleavage and by an enzymatic assay using a fluorometric substrate. Consistently, treatment with apocynin reduced calpain activity in wild-type animals receiving glutamate. These results suggest that superoxide produced by NOX2 as well as other reactive species subsequently generated are involved in calpain activation, contributing to glutamate neurotoxicity. The mechanisms underlying this process remain to be elucidated, but based on the evidence mentioned here, the observed calpain activation could likely be the result of the alteration of the intracellular calcium homeostasis due to oxidative stress.
Altogether, the present results increase our knowledge about the role of NOX2 in excitotoxic damage, a mechanism of cell death highly associated with ischemic and hypoglycemic insults, that is, neuropathologic conditions triggered by glutamate release. Our results demonstrate that NOX2 activity can be triggered by the stimulation of NMDA, non-NMDA, and metabotropic receptors and suggest that ROS generated by NOX are involved in calpain activation, contributing to glutamate-induced neuronal death. 
